Home/Filings/4/0001415889-21-004690
4//SEC Filing

Pontes Josias 4

Accession 0001415889-21-004690

CIK 0001821323other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 4:15 PM ET

Size

5.4 KB

Accession

0001415889-21-004690

Insider Transaction Report

Form 4
Period: 2021-09-30
Pontes Josias
VP, Head of Finance
Transactions
  • Award

    Common Stock

    2021-09-30+11,50013,339 total
Footnotes (2)
  • [F1]The restricted stock units set forth in this table vests as to 20% on the first anniversary of the date of grant, 30% on the second anniversary of the date of grant, and 50% on the third anniversary of the date of grant, subject to the grantee's continued service to the Company on each vesting date.
  • [F2]Includes 1,239 shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") for the purchase period of April 1, 2021 to September 30, 2021. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on September 30, 2021. This transaction is exempt under Rule 16b-3(c).

Issuer

Sigilon Therapeutics, Inc.

CIK 0001821323

Entity typeother

Related Parties

1
  • filerCIK 0001868415

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:15 PM ET
Size
5.4 KB